Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 4/20 | 0.34 |
| ▸ | CA1 | P00915 | 4/20 | 0.34 |
| ▸ | CA9 | Q16790 | 4/20 | 0.34 |
| ▸ | PREP | P48147 | 1/20 | 0.32 |
| ▸ | SHBG | P04278 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.31 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ATM | Q13315 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | PPARG | P37231 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
| ▸ | PPARA | Q07869 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1635299 | 0.93 | DRD2 (0.51) | DRD2CA2CA12CA1CA9 | |
| SCHEMBL9959203 | 0.89 | DRD2 (0.47) | DRD2LMNASMN1; SMN2ALDH1A1 | |
| SCHEMBL3960531 | 0.86 | CYP4F2 (0.40) | DRD2CA12CA1CA9CYP4F2 | |
| SCHEMBL29594393 | 0.86 | KMT2A (0.41) | DRD2SMN1; SMN2CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL9128692 | 0.86 | KMT2A (0.41) | DRD2SMN1; SMN2CYP4F2CYP4A11ALDH1A1 | |
| SCHEMBL7261819 | 0.86 | DRD2 (0.40) | DRD2CA12CA1CA9LMNA | |
| SCHEMBL9040112 | 0.86 | DRD2 (0.44) | DRD2CA2CA12CA1CA9 | |
| SCHEMBL30008548 | 0.85 | MEN1 (0.44) | LMNAKDM4EALDH1A1 | |
| SCHEMBL28706045 | 0.84 | DRD2 (0.39) | DRD2PPARGPPARDPPARA | |
| SCHEMBL22068058 | 0.83 | DRD2 (0.45) | DRD2CA2CYP4F2CYP4A11KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220109157-A1 | Conducting redox oligomers | SJOEDIN MARTIN (SE) | 2022-04-07 | — | — | US | disclosed |
| EP-3921359-A1 | CONDUCTING REDOX OLIGOMERS | Sjödin, Martin (SE) | 2021-12-15 | — | — | EP | disclosed |
| WO-2020162824-A1 | CONDUCTING REDOX OLIGOMERS | SJÖDIN MARTIN (SE) | 2020-08-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220109157-A1 | Conducting redox oligomers | NOX4, CYBB, LPO | DRD2 2405/4885CA2 1509/4885CA12 1461/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.